Who invested in Harpoon Therapeutics?
Harpoon Therapeutics's investors include OrbiMed, RA Capital Management, Cormorant Asset Management, MPM Capital and Lilly Asia Ventures, and 4 more on record.
United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$145Mraised across 2 rounds since 2017, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $100M sold, first sale Oct 2023
Reported by FinSMEsSEC filing: $25M sold, first sale May 2017
From the SEC filings it signed: 2 on the team.
On the board, as filediAndrew RobbinsJonathan DrachmanJoseph BailesLauren SilvernailMark ChinRonald HuntScott Myers
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Harpoon Therapeutics's investors include OrbiMed, RA Capital Management, Cormorant Asset Management, MPM Capital and Lilly Asia Ventures, and 4 more on record.
Harpoon Therapeutics has raised $145M across 2 rounds since 2017.
Harpoon Therapeutics's most recent round was an Undisclosed round of $100M in Oct 2023.
Its most recent round, $100M in Oct 2023, is also its largest on record.
Harpoon Therapeutics's first round on record, in May 2017, was backed by MPM Capital, Taiho Ventures and Arix Bioscience and 1 others.
Harpoon Therapeutics's latest named round is an Undisclosed round, in Oct 2023.
Harpoon Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.